SCHEDULE 13G/A: BlackRock Maintains Significant 15% Stake in STAAR Surgical Co.
Beneficial Ownership Report Amendment
BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, disclosing a continued beneficial ownership of 15.0% in STAAR Surgical Co. as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 7,401,395 shares of STAAR Surgical Co. common stock.
- This represents 15.0% of the class of securities outstanding.
- BlackRock holds sole voting power over 7,345,417 shares.
- BlackRock holds sole dispositive power over 7,401,395 shares.
- No shared voting or dispositive power was reported.
- The filing is an Amendment No. 18 to a Schedule 13G, indicating a routine update to a previously disclosed significant stake.
- One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, holds more than 5% of the total outstanding common stock of STAAR Surgical Co.
Sentiment
Score: 6
Explanation: The document indicates a continued significant institutional investment by BlackRock, suggesting ongoing confidence in STAAR Surgical Co. from a major asset manager. While not a performance report, maintaining a large stake is generally a positive signal.
Positives
- BlackRock, a major institutional investor, maintaining a significant 15.0% stake in STAAR Surgical Co. indicates continued institutional confidence in the company.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of an institutional investor's passive ownership stake and does not provide specific industry context or trends. It reflects BlackRock's continued investment in the medical device sector, specifically in a company focused on ophthalmic products.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of the previously revoked Power of Attorney. |
| 2025-01-21 | Effective date of the new Power of Attorney for BlackRock, Inc. attorneys-in-fact. |
| 2025-03-31 | Date of event which requires the filing of this statement (measurement date for beneficial ownership). |
| 2025-04-30 | Date the Schedule 13G Amendment No. 18 was signed by BlackRock, Inc. |
Keywords
STAAR Surgical Co, BlackRock, Schedule 13G, beneficial ownership, institutional investor, common stock, SEC filing, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.